Watch PTGX. Know when insiders buy.
One email the day a filing lands. Free.
PTGX
Protagonist Therapeutics, Inc
138.43
−1.10 −0.79%
USD · close Oct 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
39
FLAG · insiders 25, shorts 53
Insiders, 90 days
−$26.6M
net selling · 0 buys, 5 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
2 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $9BP/E 135.7DIV YIELD —FCF YIELD 1.46%REV TTM —NET INCOME $82.9M +59.3%NET CASH $410.2M52W 75.25 – 158.62SEC XBRL · TTM TO Invalid Date
Insider trading
−$26.6M
Net, 90 days
0 / 5
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30 | Oct 2 | Ali Asif · Chief Financial Officer | Sell | 46,034 | $141.78 | $6.5M |
| Sep 30 | Oct 2 | Ali Asif · Chief Financial Officer | Sell | 12,595 | $141.77 | $1.8M |
| Sep 10 | Sep 10 | PATEL DINESH V PH D · President and CEO | Sell | 7,278 | $144.10 | $1M |
| Sep 9 | Sep 10 | PATEL DINESH V PH D · President and CEO | Sell | 63,548 | $146.18 | $9.3M |
| Sep 8 | Sep 10 | PATEL DINESH V PH D · President and CEO | Sell | 54,174 | $145.87 | $7.9M |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.